Further analysis of the correlation between CST2 expression and survival in patients with CRC revealed that higher CST2 expression was significantly correlated with advanced CRC stages, while no difference in CST1, CST3, CST4, and CST5 expression had been noted according to CRC stage. This evidence concerns the gene CST4 and colorectal carcinoma.